Beck Capital Management, LLC Charles River Laboratories International, Inc. Transaction History

Beck Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $191,357 - $219,815	-1,530 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $51,211 - $61,648	-415 Reduced 21.34%	1,530 $217,000
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $203,874 - $285,389	1,945 New	1,945 $282,000
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $281,314 - $330,048	-2,865 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $135,580 - $159,421	-1,350 Reduced 32.03%	2,865 $314,000
Q3 2017 Nov 14, 2017	SELL	$96.72 - $109.26 $238,318 - $269,216	-2,464 Reduced 36.89%	4,215 $455,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,679	6,679 $672,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Beck Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Capital Management, LLC with notifications on news.